These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2620300)
1. Chemical combination of 6-deoxy-6-mycoloylamino-alpha,alpha-trehalose and N-acetyl-6-O-(aminoacyl)muramoyl dipeptide. Ishida H; Ogawa Y; Imai Y; Kiso M; Hasegawa A; Sakurai T; Azuma I Carbohydr Res; 1989 Dec; 194():199-208. PubMed ID: 2620300 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of some lipophilic derivatives of 1-thio-muramoyl-L-alanyl-D-isoglutamine. Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I Carbohydr Res; 1984 Aug; 131(1):61-9. PubMed ID: 6488202 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and immunoadjuvant activity of 2,2'-O-[2,2'-diacetamido-2,3,2',3'-tetradeoxy-6,6'-di-O-(2-tetradecyl- hexadecanoyl)-alpha,alpha'-trehalose-3,3'-diyl]bis(N-D-lactoyl-L-alanyl -D-isoglutamine). Ishida H; Imai Y; Kiso M; Hasegawa A; Sakurai T; Azuma I Carbohydr Res; 1989 Dec; 195(1):59-66. PubMed ID: 2636046 [TBL] [Abstract][Full Text] [Related]
4. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity. Okumura H; Tokushima Y; Saiki I; Azuma I; Kiso M; Hasegawa A Carbohydr Res; 1983 Oct; 122(1):87-98. PubMed ID: 6652634 [TBL] [Abstract][Full Text] [Related]
5. Regression of line-10 hepatocellular carcinoma by a less toxic cord factor analogue combined with L18-MDP or synthetic lipid A analogues. Ishida H; Saiki I; Saito S; Hasegawa A; Kiso M; Azuma I Vaccine; 1988 Oct; 6(5):440-4. PubMed ID: 3195200 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of N-acetyl-1-thiomuramoyl-L-alanyl-D-isoglutamine and some of its lipophilic derivatives. Hasegawa A; Hioki Y; Kiso M; Okumura H; Azuma I Carbohydr Res; 1983 Nov; 123(2):183-99. PubMed ID: 6661739 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of O-N-acetyl-beta-muramoyl-L-alanyl-D-isoglutamine)-(1 leads to 6)-2-acylamino-2-deoxy-D-glucoses. Hasegawa A; Ozaki M; Goh Y; Kiso M; Azuma I Carbohydr Res; 1982 Mar; 100():235-45. PubMed ID: 7083252 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide. Durette PL; Dorn CP; Friedman A; Schlabach A J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480 [TBL] [Abstract][Full Text] [Related]
9. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs. Woodard LF; Toone NM; Jasman RL Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042 [TBL] [Abstract][Full Text] [Related]
10. Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6'-dicorynomycolate. Yamamoto H; Oda M; Nakano M; Watanabe N; Yabiku K; Shibutani M; Inoue M; Imagawa H; Nagahama M; Himeno S; Setsu K; Sakurai J; Nishizawa M J Med Chem; 2013 Jan; 56(1):381-5. PubMed ID: 23210481 [TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2. Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716 [No Abstract] [Full Text] [Related]
12. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs. Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372 [TBL] [Abstract][Full Text] [Related]
13. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation. Solange A Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782 [TBL] [Abstract][Full Text] [Related]
14. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines. Woodard LF; Toone NM; McLaughlin CA Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304 [TBL] [Abstract][Full Text] [Related]
15. Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs. Byars NE Infect Immun; 1984 May; 44(2):344-50. PubMed ID: 6609127 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine. Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813 [No Abstract] [Full Text] [Related]
17. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets. Masihi KN; Lange W; Rohde-Schulz B Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of (N-acetyl-1-O-acylmuramoyl)-L-alanyl-D-isoglutamines, and their immunoadjuvant activities. Hasegawa A; Hioki Y; Kiso M; Azuma I Carbohydr Res; 1983 Nov; 123(1):63-71. PubMed ID: 6667479 [TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis and biological activities of 6,6'-di-O-mycoloyl-beta,beta- and -alpha,beta-trehalose. Azuma I; Sakurai T; Ishida H; Kitajima T; Yamazaki M Carbohydr Res; 1991 Jun; 212():47-53. PubMed ID: 1959122 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities. Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]